Susquehanna International Group
DWTX

Susquehanna International Group’s Dogwood Therapeutics DWTX Stock Holding History

Susquehanna International Group’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-440
Closed -$10.1K – 13454
2023
Q3 		$10.1K Buy
+440
New +$15.3K ﹤0.01% 11716
2023
Q1 		– Sell
-1,460
Closed -$8.76K – 13648
2022
Q4 		$8.76K Sell
1,460
-1,860
-56% -$14K ﹤0.01% 11955
2022
Q3 		$32K Buy
+3,320
New +$468K ﹤0.01% 12426

Other funds holding DWTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group's DWTX Position: Q3 2024 in Review

Susquehanna International Group sold out of Dogwood Therapeutics (DWTX) in Q3 2024, closing a stake of 2,640 shares — an estimated $14.2K sold.

Susquehanna International Group first reported a position in DWTX in Q1 2022 and held it in 7 quarters. The position peaked at $97K in Q2 2022. 24 funds tracked by Wall St. Rank hold DWTX as of Q3 2024.

  • Susquehanna International Group reported no remaining Dogwood Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 2,640 Dogwood Therapeutics shares in Q3 2024, an estimated $14.2K.
  • Susquehanna International Group first reported a position in Dogwood Therapeutics in Q1 2022 and held it in 7 quarters.
  • Susquehanna International Group's Dogwood Therapeutics position peaked at $97K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.